187
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Quetiapine attenuates the acquisition of morphine-induced conditioned place preference and reduces ERK phosphorylation in the hippocampus and cerebral cortex

, , , , , , , & ORCID Icon show all
Pages 422-432 | Received 04 Oct 2021, Accepted 18 Apr 2022, Published online: 03 Jun 2022

References

  • Bagherpasand N, Mehri S, Jafari Shahroudi M, Tabatabai SM, Khezri A, Fathi M, Abnous K, Imenshahidi M, Hosseinzadeh H.Effect of topiramate on morphine-induced conditioned place preference (CPP) in rats: role of ERK and CREB proteins in hippocampus and cerebral cortex. Iran J Pharm Res. 2019;18:2000–10.doi:10.22037/ijpr.2019.1100873.
  • Esmaili-Shahzade-Ali-Akbari P, Hosseinzadeh H, Mehri S. Effect of suvorexant on morphine tolerance and dependence in mice: role of NMDA, AMPA, ERK and CREB proteins. Neurotoxicology. 2021;84:64–72.doi:10.1016/j.neuro.2021.02.005.
  • Ballantyne JC, LaForge SK.Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129:235–55.doi:10.1016/j.pain.2007.03.028.
  • Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ.A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev. 2010;30:155–66.doi:10.1016/j.cpr.2009.10.006.
  • Imenshahidi M, Qaredashi R, Hashemzaei M, Hosseinzadeh H.Inhibitory Effect of Berberis vulgaris aqueous extract on acquisition and reinstatement effects of morphine in conditioned place preferences (CPP) in mice. Jundishapur J Nat Pharm Prod. 2014;9:e16145.doi:10.17795/jjnpp-16145.
  • Do Couto BR, Aguilar M, Manzanedo C, Rodriguez-Arias M, Minarro J.NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference. Brain Res Bull. 2005;64:493–503. doi:10.1016/j.brainresbull.2004.10.005.
  • Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodríguez-Arias M, Miñarro J.Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1035–43.doi:10.1016/j.pnpbp.2004.05.038.
  • Popik P, Wrobel M, Bisaga A.Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology. 2006;31:160–70. doi:10.1038/sj.npp.1300760.
  • Morón JA, Gullapalli S, Taylor C, Gupta A, Gomes I, Devi LA.Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology. 2010;35:955–66.doi:10.1038/npp.2009.199.
  • Ferbinteanu J, McDonald RJ.Dorsal/ventral hippocampus, fornix, and conditioned place preference. Hippocampus. 2001;11:187–200.doi:10.1002/hipo.1036.
  • Corrigall WA, Linseman MA.Conditioned place preference produced by intra-hippocampal morphine. Pharmacol Biochem Behav. 1988;30:787–89.doi:10.1016/0091-3057(88)90100-1.
  • Dong Z, Han H, Wang M, Xu L, Hao W, Cao J.Morphine conditioned place preference depends on glucocorticoid receptors in both hippocampus and nucleus accumbens. Hippocampus. 2006;16:809–13.doi:10.1002/hipo.20216.
  • Motlagh PD, Kachuei M, Noormohamadi A, Falahi S, Alaei H. Evaluation of medical prefrontal cortex (mPFC) stimulation and destruction effects on addiction to morphine. J Isfahan Med Sch. 2013;31:25–34.
  • Lin X, Wang Q, Ji J, Yu LC.Role of MEK-ERK pathway in morphine-induced conditioned place preference in ventral tegmental area of rats. J Neurosci Res. 2010;88:1595–604.doi:10.1002/jnr.22326.
  • Pascual MM, Pastor V, Bernabeu RO.Nicotine-Conditioned place preference induced CREB phosphorylation and Fos expression in the adult rat brain. Psychopharmacology (Berl). 2009;207:57–71.doi:10.1007/s00213-009-1630-4.
  • Tropea TF, Kosofsky BE, Rajadhyaksha AM.Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior. J Neurochem. 2008;106:1780–90.doi:10.1111/j.1471-4159.2008.05518.x.
  • Girault JA, Valjent E, Caboche J, Hervé D.ERK2: a logical and gate critical for drug-induced plasticity? Curr Opin Pharmacol. 2007;7:77–85.doi:10.1016/j.coph.2006.08.012.
  • Haghparast A, Fatahi Z, Alamdary SZ, Reisi Z, Khodagholi F.Changes in the levels of p-ERK, p-CREB, and c-fos in rat mesocorticolimbic dopaminergic system after morphine-induced conditioned place preference: the role of acute and subchronic stress. Cell Mol Neurobiol. 2014;34:277–88.doi:10.1007/s10571-013-0011-z.
  • Carlezon WA Jr., Duman RS, Nestler EJ.The many faces of CREB. Trends Neurosci. 2005;28:436–45.doi:10.1016/j.tins.2005.06.005.
  • Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R.Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci. 2001;14:1091–104.doi:10.1046/j.0953-816x.2001.01731.x.
  • Zhou LF, Zhu YP.Changes of CREB in rat hippocampus, prefrontal cortex and nucleus accumbens during three phases of morphine induced conditioned place preference in rats. J Zhejiang Univ Sci B. 2006;7:107–13.doi:10.1631/jzus.2006.B0107.
  • McIntyre A, Gendron A, McIntyre A.Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study. Depress Anxiety. 2007;24:487–94.doi:10.1002/da.20275.
  • Riedel M, Müller N, Spellmann I, Engel RR, Musil R, Valdevit R, Dehning S, Douhet A, Cerovecki A, Strassnig M, et al. Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2007;257:402–12.doi:10.1007/s00406-007-0748-9.
  • Sanford M, Keating GM.Quetiapine: a review of its use in the management of bipolar depression. CNS Drugs. 2012;26:435–60.doi:10.2165/11203840-000000000-00000.
  • Dando TM, Keating GM.Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder. Drugs. 2005;65:2533–51.doi:10.2165/00003495-200565170-00008.
  • Wang H, Zhang Y, Qiao M.Mechanisms of extracellular signal-regulated kinase/camp response element-binding protein/brain-derived neurotrophic factor signal transduction pathway in depressive disorder. Neural Regen Res. 2013;8:843–52.doi:10.3969/j.issn.1673-5374.2013.09.009.
  • Di Benedetto B, Kühn R, Nothdurfter C, Rein T, Wurst W, Rupprecht R.N-Desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant. Neuropharmacology. 2012;62:209–16.doi:10.1016/j.neuropharm.2011.07.001.
  • Kampman KM, Pettinati HM, Lynch KG, Whittingham T, Macfadden W, Dackis C, Tirado C, Oslin DW, Sparkman T, O’-Brien CP.A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of type A and type B alcoholism. J Clin Psychopharmacol. 2007;27:344–51.doi:10.1097/JCP.0b013e3180ca86e5.
  • Litten RZ, Fertig JB, Falk DE, Ryan ML, Mattson ME, Collins JF, Murtaugh C, Ciraulo D, Green AI, Johnson B, et al. A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcohol Clin Exp Res. 2012;36:406–16.doi:10.1111/j.1530-0277.2011.01649.x.
  • Han J, Wang G, Liu M, Chai R, Guo J, Zhang F, Lu C, Zhang Y, Wang H, Zhang R. Effects of quetiapine on behavioral changes and expression of myelin proteins in a chronic alcohol dependence rat model. Behav Brain Res. 2020;385:112561.doi:10.1016/j.bbr.2020.112561.
  • Hanley MJ, Kenna GA.Quetiapine: treatment for substance abuse and drug of abuse. Am J Health Syst Pharm. 2008;65:611–18.doi:10.2146/ajhp070112.
  • Gallo A, Lapointe S, Stip E, Potvin S, Rompré PP.Quetiapine blocks cocaine-induced enhancement of brain stimulation reward. Behav Brain Res. 2010;208:163–68.doi:10.1016/j.bbr.2009.11.029.
  • He J, Xu H, Yang Y, Zhang X, Li XM.Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats. Behav Brain Res. 2005;160:178–87.doi:10.1016/j.bbr.2004.11.028.
  • Huston JP, Silva MA, Topic B, Müller CP.What’s conditioned in conditioned place preference? Trends Pharmacol Sci. 2013;34:162–66.doi:10.1016/j.tips.2013.01.004.
  • Rezayof A, Nazari-Serenjeh F, Zarrindast M-R, Sepehri H, Delphi L.Morphine-Induced place preference: involvement of cholinergic receptors of the ventral tegmental area. Eur J Pharmacol. 2007;562:92–102.doi:10.1016/j.ejphar.2007.01.081.
  • Moaddab M, Haghparast A, Hassanpour-Ezatti M.Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav Brain Res. 2009;198:466–71.doi:10.1016/j.bbr.2008.11.030.
  • Maleki SA, Samini M, Babapour V, Mehr SE, Cheraghiyan S, Nouri MH.Potentiation of morphine-induced conditioned place preference with concurrent use of amantadine and fluvoxamine by the intraperitoneal and intracerebroventricular injection in rat. Behav Brain Res. 2008;190:189–92.doi:10.1016/j.bbr.2008.02.027.
  • McLelland AE, Martin-Iverson MT, Beninger RJ.The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine. Psychopharmacology (Berl). 2014;231:4349–59.doi:10.1007/s00213-014-3578-2.
  • Popik P, Kolasiewicz W.Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:288–94.doi:10.1007/pl00005354.
  • Mohammadzadeh L, Hosseinzadeh H, Abnous K, Razavi BM.Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats. Environ Sci Pollut Res Int. 2018;25:4904–14.doi:10.1007/s11356-017-0842-0.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.doi:10.1006/abio.1976.9999.
  • Mehri S, Sajjadi SS, Tabatabai SM, Hosseinzadeh H.Effects of clavulanic acid on the acquisition and reinstatement following morphine-induced conditioned place preference in mice. Basic Clin Neurosci. 2018;9:289–96.doi:10.32598/bcn.9.4.289.
  • Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani A.Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J Psychopharmacol. 2003;17:415–23.doi:10.1177/0269881103174005.
  • Spampinato U, Esposito E, Romandini S, Samanin R.Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus. Brain Res. 1985;328:89–95.doi:10.1016/0006-8993(85)91326-5.
  • Tao R, Auerbach SB.Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J Neurochem. 1994;63:517–24.doi:10.1046/j.1471-4159.1994.63020517.x.
  • Parsons LH, Weiss F, Koob GF.Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement. Psychopharmacology (Berl). 1996;128:150–60.doi:10.1007/s002130050120.
  • Pothos E, Rada P, Mark GP, Hoebel BG.Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 1991;566:348–50.doi:10.1016/0006-8993(91)91724-f.
  • Prieto E, Micó JA, Meana JJ, Majadas S.Neurobiological bases of quetiapine antidepressant effect in the bipolar disorder. Actas Esp Psiquiatr. 2010;38:22–32.
  • Manzanedo C, Aguilar MA, Rodríguez-Arias M, Miñarro J.Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res. 2001;121:189–97.doi:10.1016/s0166-4328(01)00164-4.
  • Patti CL, Frussa-Filho R, Silva RH, Carvalho RC, Kameda SR, Takatsu-Coleman AL, Cunha JL, Abílio VC.Behavioral characterization of morphine effects on motor activity in mice. Pharmacol Biochem Behav. 2005;81:923–27.doi:10.1016/j.pbb.2005.07.004.
  • Blanc G, Hervé D, Simon H, Lisoprawski A, Glowinski J, Tassin JP.Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation. Nature. 1980;284:265–67.doi:10.1038/284265a0.
  • Borgkvist A, Valjent E, Santini E, Hervé D, Girault JA, Fisone G.Delayed, context- and dopamine D1 receptor-dependent activation of ERK in morphine-sensitized mice. Neuropharmacology. 2008;55:230–37.doi:10.1016/j.neuropharm.2008.05.028.
  • Watts SW, Yang P, Banes AK, Baez M.Activation of ERK mitogen-activated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol. 2001;38:539–51.doi:10.1097/00005344-200110000-00006.
  • Crow T, Xue-Bian JJ, Siddiqi V, Neary JT.Serotonin activation of the ERK pathway in hermissenda: contribution of calcium-dependent protein kinase C. J Neurochem. 2001;78:358–64.doi:10.1046/j.1471-4159.2001.00404.x.
  • Siahposht-Khachaki A, Fatahi Z, Yans A, Khodagholi F, Haghparast A.Involvement of AMPA/Kainate glutamate receptor in the extinction and reinstatement of morphine-induced conditioned place preference: a behavioral and molecular study. Cell Mol Neurobiol. 2017;37:315–28.doi:10.1007/s10571-016-0371-2.
  • Siahposht-Khachaki A, Ezzatpanah S, Razavi Y, Haghparast A. NMDA receptor dependent changes in c-fos and p-CREB signaling following extinction and reinstatement of morphine place preference. Neurosci Lett. 2018;662:147–51.doi:10.1016/j.neulet.2017.10.028.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.